Rekah Pharmaceutical Industry Ltd. (TLV:REKA)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
1,261.00
-143.00 (-10.19%)
Apr 29, 2025, 5:32 PM IDT
-3.81%
Market Cap 146.79M
Revenue (ttm) 321.71M
Net Income (ttm) 6.21M
Shares Out 11.41M
EPS (ttm) 0.54
PE Ratio 23.81
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 14,512
Average Volume 5,304
Open 1,404.00
Previous Close 1,404.00
Day's Range 1,261.00 - 1,404.00
52-Week Range 1,130.00 - 1,601.00
Beta 0.09
RSI 54.88
Earnings Date May 26, 2025

About TLV:REKA

Rekah Pharmaceutical Industry Ltd. engages in the manufacture, marketing, sale, and distribution of pharmaceuticals, cosmetics, vitamins and nutritional supplements, and medical devices in Israel. The company offers steroid tablets; antibiotics, including penicillin and cephalosporin; drops and ointments to treat allergies, infections, and dryness of the eyes; baby products; and dermatological preparations. Its portfolio of products comprise generic Rx and OTC drugs used in various therapeutic fields, such as urinary tract pain, steroid anti-in... [Read more]

Sector Healthcare
Founded 1947
Employees 421
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol REKA
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.